PILOT AND FEASIBILIY PROGRAM

试点和可行性计划

基本信息

  • 批准号:
    6612281
  • 负责人:
  • 金额:
    $ 30.32万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2002
  • 资助国家:
    美国
  • 起止时间:
    2002-12-01 至 2007-11-30
  • 项目状态:
    已结题

项目摘要

Description (adapted from the application) Eligibility: The research supported by the Pilot and Feasibility Studies Program is primarily intended to be a first grant for junior faculty at the U Washington who have not yet obtained a major peer-reviewed grant (such as an R01 or K21) in the areas of diabetes or endocrinology. Senior faculty members are also eligible to apply if their projects represent first entry into the field of diabetes research. Established investigators in diabetes are also eligible if their purpose is to test innovative ideas that truly represent a clear departure from previous research activity. Any single investigator is eligible to receive a P and F award only once, unless the second P and F is a clear departure from the research area of the original award. Funding level: Since NIH funding to our DERC P and F Studies Program has been $50,000 per year for all P and F projects combined, up to now there has been limited support for each project to a maximum of $25,000 yearly. Awards are made initially for one year, but a second year?s funding is provided if satisfactory progress is made during the first year. Despite these limited funds, there has been a large response to calls for applications and numerous meritorious research projects have been supported. As a result of increased funding to the Diabetes Center for P and F studies, an increase in the funding level and the number of awards in the P and F program is proposed. It is intended that $200,000 of the new DERC budget be allocated to P and F research awards. Recipients must be members of the U. Washington faculty (postdoctoral fellows and research scientists are not eligible) and meet established criteria. The awards will be limited to $50,000 per year for 2 years but some may be smaller. The awards are made on the basis of scientific merit, following rigorous scientific review procedures that have been used in for past applications. New Investigator Awards: The DERC Studies Program also administers the Diabetes Investigator Award Program of $25,000 per year to members of the faculty who are making their first entry into diabetes research. These awards are supported to the private DRTP, an endowed fund of the UW to foster diabetes research. The eligibility and evaluation criteria are the same as the P and F program. Fellowships: The P and F program also administers the McAbee Fellowship Program that is also privately funded by the DRTP.
描述(根据应用程序改编)资格:飞行员和可行性研究计划支持的研究主要是为U华盛顿的初级教师提供的首个赠款,他们尚未获得糖尿病或内分泌学领域的主要同行评审赠款(例如R01或K21)。 Senior faculty members are also eligible to apply if their projects represent first entry into the field of diabetes research.如果他们的目的是测试真正代表与以前的研究活动明显不同的创新思想,那么糖尿病中既定的研究人员也有资格。除非第二个P和F与原始奖项的研究领域明显不同,否则任何一个调查人员都有资格仅获得P和F奖。 资金级别:由于我们的DERC P和F研究计划的NIH资金为所有P和F项目的总合计为每年50,000美元,因此到目前为止,每个项目的支持有限,每年最高25,000美元。 Awards are made initially for one year, but a second year?s funding is provided if satisfactory progress is made during the first year.尽管这些资金有限,但对申请的呼吁有很大的回应,并且支持了许多有功的研究项目。由于向糖尿病中心进行P和F研究中心的资金增加,提出了资金水平的提高和P和F计划中的奖励数量。 It is intended that $200,000 of the new DERC budget be allocated to P and F research awards.接收者必须是美国华盛顿教师的成员(博士后研究员和研究科学家没有资格),并符合既定标准。 The awards will be limited to $50,000 per year for 2 years but some may be smaller.该奖项是根据科学的优点颁发的,遵循用于过去应用的严格科学审查程序。 New Investigator Awards: The DERC Studies Program also administers the Diabetes Investigator Award Program of $25,000 per year to members of the faculty who are making their first entry into diabetes research. These awards are supported to the private DRTP, an endowed fund of the UW to foster diabetes research. The eligibility and evaluation criteria are the same as the P and F program. Fellowships: The P and F program also administers the McAbee Fellowship Program that is also privately funded by the DRTP.

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DENIS G. BASKIN其他文献

DENIS G. BASKIN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DENIS G. BASKIN', 18)}}的其他基金

Core--Histochemistry
核心--组织化学
  • 批准号:
    7475877
  • 财政年份:
    2007
  • 资助金额:
    $ 30.32万
  • 项目类别:
Core--Histochemistry
核心--组织化学
  • 批准号:
    6844978
  • 财政年份:
    2004
  • 资助金额:
    $ 30.32万
  • 项目类别:
CYTOHISTOCHEMISTRY CORE
细胞组织化学核心
  • 批准号:
    6612276
  • 财政年份:
    2002
  • 资助金额:
    $ 30.32万
  • 项目类别:
PILOT AND FEASIBILITY STUDIES
试点和可行性研究
  • 批准号:
    6296335
  • 财政年份:
    1999
  • 资助金额:
    $ 30.32万
  • 项目类别:
PILOT AND FEASIBILITY STUDIES
试点和可行性研究
  • 批准号:
    6300972
  • 财政年份:
    1999
  • 资助金额:
    $ 30.32万
  • 项目类别:
CORE--CYTOHISTOCHEMISTRY FACILITY
核心--细胞组织化学设施
  • 批准号:
    6296337
  • 财政年份:
    1999
  • 资助金额:
    $ 30.32万
  • 项目类别:
PILOT AND FEASIBILITY STUDIES
试点和可行性研究
  • 批准号:
    6105007
  • 财政年份:
    1999
  • 资助金额:
    $ 30.32万
  • 项目类别:
CORE--CYTOHISTOCHEMISTRY FACILITY
核心--细胞组织化学设施
  • 批准号:
    6105009
  • 财政年份:
    1999
  • 资助金额:
    $ 30.32万
  • 项目类别:
CORE--CYTOHISTOCHEMISTRY FACILITY
核心--细胞组织化学设施
  • 批准号:
    6300974
  • 财政年份:
    1999
  • 资助金额:
    $ 30.32万
  • 项目类别:
PILOT AND FEASIBILITY STUDIES
试点和可行性研究
  • 批准号:
    6270412
  • 财政年份:
    1998
  • 资助金额:
    $ 30.32万
  • 项目类别:

相似国自然基金

丝氨酸蛋白酶PR3调控肾足细胞损伤介导糖尿病肾脏病的作用及苓桂术甘汤效应机制研究
  • 批准号:
    82374171
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
探究和营清热方及其重要单体绿原酸下调AGEs/SOGA1信号通路抑制糖尿病视网膜病变的作用机制
  • 批准号:
    82305319
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
面向糖尿病足溃疡治疗的诱导电荷电渗微藻重组方法研究
  • 批准号:
    62304034
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
声控M2型巨噬细胞源性囊泡药物递送系统重塑糖尿病足炎性微环境用于调控末梢神经的作用及机制研究
  • 批准号:
    82302849
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于巨噬细胞源外泌体miR-7-5p驱动炎症小体激活介导的足细胞焦亡探讨肾康方延缓糖尿病肾病的作用机制
  • 批准号:
    82305218
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

DULCE (Diabetes InqUiry Through a Learning Collaborative Experience)
DULCE(通过学习协作体验进行糖尿病查询)
  • 批准号:
    10558119
  • 财政年份:
    2023
  • 资助金额:
    $ 30.32万
  • 项目类别:
Society of Behavioral Medicine 2023 Annual Meeting & Scientific Sessions
行为医学学会2023年年会
  • 批准号:
    10681958
  • 财政年份:
    2023
  • 资助金额:
    $ 30.32万
  • 项目类别:
Maternal Fetal Medicine Units Network: University of California, San Francisco
母胎医学单位网络:加州大学旧金山分校
  • 批准号:
    10682872
  • 财政年份:
    2023
  • 资助金额:
    $ 30.32万
  • 项目类别:
Social and Dietary Determinants of Kidney Stone Risk
肾结石风险的社会和饮食决定因素
  • 批准号:
    10643740
  • 财政年份:
    2023
  • 资助金额:
    $ 30.32万
  • 项目类别:
Share plus: Continuous Glucose Monitoring with Data Sharing in Older Adults with T1D and Their Care Partners
分享加:患有 T1D 的老年人及其护理伙伴的持续血糖监测和数据共享
  • 批准号:
    10660793
  • 财政年份:
    2023
  • 资助金额:
    $ 30.32万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了